Pharmacodynamics of Selective Inhibition of γ-Secretase by Avagacestat

被引：56

作者：

Albright, Charles F. ^{[1
]}

Dockens, Randy C. ^{[2
]}

Meredith, Jere E., Jr. ^{[1
]}

Olson, Richard E. ^{[1
]}

Slemmon, Randy ^{[2
]}

Lentz, Kimberley A. ^{[1
]}

Wang, Jun-Sheng ^{[3
]}

Denton, R. Rex ^{[1
]}

Pilcher, Gary ^{[1
]}

Rhyne, Paul W. ^{[3
]}

Raybon, Joseph J. ^{[1
]}

Barten, Donna M. ^{[1
]}

Burton, Catherine ^{[1
]}

Toyn, Jeremy H. ^{[1
]}

Sankaranarayanan, Sethu ^{[1
]}

Polson, Craig ^{[1
]}

Guss, Valerie ^{[1
]}

White, Randy ^{[4
]}

Simutis, Frank ^{[4
]}

Sanderson, Thomas ^{[4
]}

Gillman, Kevin W. ^{[1
]}

Starrett, John E., Jr. ^{[1
]}

Bronson, Joanne ^{[1
]}

Sverdlov, Oleksandr ^{[3
]}

Huang, Shu-Pang ^{[3
]}

Castaneda, Lorna ^{[3
]}

Feldman, Howard ^{[1
]}

Coric, Vlad ^{[1
]}

Zaczek, Robert ^{[1
]}

Macor, John E. ^{[1
]}

Houston, John ^{[1
]}

Berman, Robert M. ^{[1
]}

Tong, Gary ^{[2
]}

机构：

[1] Bristol Myers Squibb Co, Res & Dev, Wallingford, CT 06492 USA

[2] Bristol Myers Squibb Co, Hopewell Facil, Res & Dev, Pennington, NJ USA

[3] Bristol Myers Squibb Co, Res & Dev, Lawrenceville, NJ USA

[4] Bristol Myers Squibb Co, Dept Drug Safety Evaluat, Mt Vernon Facil, Res & Dev, Evansville, IN USA

来源：

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2013年 / 344卷 / 03期

关键词：

4 BASIC MODELS; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; HEALTHY-YOUNG; MOUSE MODEL; NOTCH; BMS-708163; DISCOVERY; MECHANISM; RECEPTOR;

D O I：

10.1124/jpet.112.199356

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

A hallmark of Alzheimer's disease (AD) pathology is the accumulation of brain amyloid beta-peptide (A beta), generated by gamma-secretase-mediated cleavage of the amyloid precursor protein (APP). Therefore, gamma-secretase inhibitors (GSIs) may lower brain A beta and offer a potential new approach to treat AD. As gamma-secretase also cleaves Notch proteins, GSIs can have undesirable effects due to interference with Notch signaling. Avagacestat (BMS-708163) is a GSI developed for selective inhibition of APP over Notch cleavage. Avagacestat inhibition of APP and Notch cleavage was evaluated in cell culture by measuring levels of A beta and human Notch proteins. In rats, dogs, and humans, selectivity was evaluated by measuring plasma blood concentrations in relation to effects on cerebrospinal fluid (CSF) A beta levels and Notch-related toxicities. Measurements of Notch-related toxicity included goblet cell metaplasia in the gut, marginal-zone depletion in the spleen, reductions in B cells, and changes in expression of the Notch-regulated hairy and enhancer of split homolog-1 from blood cells. In rats and dogs, acute administration of avagacestat robustly reduced CSF A beta 40 and A beta 42 levels similarly. Chronic administration in rats and dogs, and 28-day, single- and multiple-ascending-dose administration in healthy human subjects caused similar exposure-dependent reductions in CSF A beta 40. Consistent with the 137-fold selectivity measured in cell culture, we identified doses of avagacestat that reduce CSF A beta levels without causing Notch-related toxicities. Our results demonstrate the selectivity of avagacestat for APP over Notch cleavage, supporting further evaluation of avagacestat for AD therapy.

引用

页码：686 / 695

页数：10

共 53 条

[31] Moderate reduction of γ-secretase attenuates amyloid burden and limits mechanism-based liabilities [J].

Li, Tong ;

Wen, Hongjin ;

Brayton, Cory ;

Laird, Fiona M. ;

Ma, Guojun ;

Peng, Shiwen ;

Placanica, Lisa ;

Wu, T. C. ;

Crain, Barbara J. ;

Price, Donald L. ;

Eberhart, Charles G. ;

Wong, Philip C. .

JOURNAL OF NEUROSCIENCE, 2007, 27 (40) :10849-10859

[32] Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer's Disease [J].

Martone, Robert L. ;

Zhou, Hua ;

Atchison, Kevin ;

Comery, Thomas ;

Xu, Jane Z. ;

Huang, Xinyi ;

Gong, Xioahai ;

Jin, Mei ;

Kreft, Anthony ;

Harrison, Boyd ;

Mayer, Scott C. ;

Aschmies, Suzan ;

Gonzales, Cathleen ;

Zaleska, Margaret M. ;

Riddell, David R. ;

Wagner, Erik ;

Lu, Peimin ;

Sun, Shaiu-Ching ;

Sonnenberg-Reines, June ;

Oganesian, Aram ;

Adkins, Karissa ;

Leach, Michael W. ;

Clarke, David W. ;

Huryn, Donna ;

Abou-Gharbia, Magid ;

Magolda, Ronald ;

Bard, Jonathan ;

Frick, Glen ;

Raje, Sangeeta ;

Forlow, S. Bradley ;

Balliet, Carrie ;

Burczynski, Michael E. ;

Reinhart, Peter H. ;

Wan, Hong I. ;

Pangalos, Menelas N. ;

Jacobsen, J. Steven .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (02) :598-608

[33] Modulation of notch processing by γ-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation [J].

Milano, J ;

McKay, J ;

Dagenais, C ;

Foster-Brown, L ;

Pognan, F ;

Gadient, R ;

Jacobs, RT ;

Zacco, A ;

Greenberg, B ;

Ciaccio, PJ .

TOXICOLOGICAL SCIENCES, 2004, 82 (01) :341-358

[34] Differential Effects between γ-Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice [J].

Mitani, Yasuyuki ;

Yarimizu, Junko ;

Saita, Kyoko ;

Uchino, Hiroshi ;

Akashiba, Hiroki ;

Shitaka, Yoshitsugu ;

Ni, Keni ;

Matsuoka, Nobuya .

JOURNAL OF NEUROSCIENCE, 2012, 32 (06) :2037-2050

[35] Recent progress in the medicinal chemistry of γ-secretase inhibitors [J].

Olson, Richard E. ;

Albright, Charles F. .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (01) :17-33

[36]

Pollack Scott J, 2005, Curr Opin Investig Drugs, V6, P35

[37] Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796):: A γ-secretase inhibitor with Aβ lowering activity in a transgenic mouse model of Alzheimer's disease [J].

Prasad, C. V. C. ;

Zheng, Ming ;

Vig, Shikha ;

Bergstrom, Carl ;

Smith, David W. ;

Gao, Qi ;

Yeola, Suresh ;

Polson, Craig T. ;

Corsa, Jason A. ;

Guss, Valerie L. ;

Loo, Alice ;

Wang, Jian ;

Sleczka, Bogdan G. ;

Dangler, Charles ;

Robertson, Barbara J. ;

Hendrick, Joseph P. ;

Roberts, Susan B. ;

Barten, Donna M. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (14) :4006-4011

[38] MECHANISMS OF DISEASE Alzheimer's Disease [J].

Querfurth, Henry W. ;

LaFerla, Frank M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (04) :329-344

[39] Notch regulation of lymphocyte development and function [J].

Radtke, F ;

Wilson, A ;

Mancini, SJC ;

MacDonald, HR .

NATURE IMMUNOLOGY, 2004, 5 (03) :247-253

[40] Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2 [J].

Riccio, Orbicia ;

van Gijn, Marielle E. ;

Bezdek, April C. ;

Pellegrinet, Luca ;

van Es, Johan H. ;

Zimber-Strobl, Ursula ;

Strobl, Lothar J. ;

Honjo, Tasuku ;

Clevers, Hans ;

Radtke, Freddy .

EMBO REPORTS, 2008, 9 (04) :377-383

← 1 2 3 4 5 6 →